Search the Newsreel

Focus Partners Advisor Solutions LLC Buys Shares of 22,528 The Boeing Company $BA

Focus Partners Advisor Solutions LLC acquired 22,528 shares of The Boeing Company (NYSE:BA) in Q2, valued at approximately $4.877 million, marking a new position for the firm. Several other institutional investors also increased their holdings in Boeing, bringing institutional ownership to 64.82%. The article …

Focus Partners Advisor Solutions LLC Buys New Stake in The Travelers Companies, Inc. $TRV

Focus Partners Advisor Solutions LLC has acquired a new stake of 9,521 shares in The Travelers Companies, Inc. (NYSE:TRV) during the second quarter, valued at approximately $3.14 million. This article details institutional investor activity, insider transactions, stock performance metrics, and recent analyst ratings for …

36,742 Shares in Southern Company (The) $SO Bought by Family Legacy Inc.

Family Legacy Inc. recently acquired 36,742 shares of Southern Company (NYSE:SO) during the second quarter, a stake valued at approximately $3.52 million. This purchase contributes to the 64.1% institutional ownership of Southern's stock. Southern Company reported quarterly EPS of $1.13, surpassing analyst estimates, but …

More than 1 million attic ladders sold at Home Depot, Lowe’s recalled after reported injuries

Louisville Ladder Inc. has recalled 1.77 million attic stairway ladders, sold under various brand names at major retailers like Home Depot and Lowe's. The recall was issued due to reports of bolts breaking, which has led to falls and injuries, including one report of …

The TJX Companies, Inc. $TJX Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

The Commonwealth of Pennsylvania Public School Employees’ Retirement System reduced its stake in The TJX Companies by 5.6% in the second quarter, selling 14,431 shares. Despite this, institutional investors collectively own 91.09% of TJX, and analysts remain largely bullish with an average "Buy" rating …

Crossmark Global Holdings Inc. Boosts Holdings in The TJX Companies, Inc. $TJX

Crossmark Global Holdings Inc. increased its stake in The TJX Companies, Inc. by 5.3% in the second quarter, now owning 415,918 shares valued at $63 million. Institutional investors collectively hold 91.09% of TJX stock, and analysts maintain a "Buy" rating with an average price …

Citizens & Northern Corp Takes Position in Wells Fargo & Company $WFC

Empowered Funds LLC Buys 12,071 Shares of Norfolk Southern Corporation $NSC

Empowered Funds LLC significantly increased its stake in Norfolk Southern Corporation (NYSE:NSC) by 91.7% in the first quarter, purchasing 12,071 additional shares and bringing its total holding to approximately $7.24 million. Despite institutional investors owning 75.1% of the company, analysts maintain a cautious "Hold" …

ABN AMRO Bank N.V. Takes $937,000 Position in The Ensign Group, Inc. $ENSG

ABN AMRO Bank N.V. has acquired a new position of 5,858 shares, valued at $937,000, in The Ensign Group, Inc. during the second quarter. This move comes as several other institutional investors have also adjusted their holdings in ENSG, with notable increases from Mitsubishi …

Mineralys Therapeutics, Inc. $MLYS Shares Bought by Bank of America Corp DE

Hackett Group (HCKT) Q2 2026 Earnings Call Transcript

Wall Street Zen Upgrades Avalo Therapeutics (NASDAQ:AVTX) to Hold

Wall Street Zen has upgraded Avalo Therapeutics (NASDAQ:AVTX) from a "sell" to a "hold" rating, though the consensus among other analysts remains a "Moderate Buy" with an average price target of $45.10. The company reported a quarterly loss of $0.83 per share, missing estimates. …

Atara Biotherapeutics (NASDAQ:ATRA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen has upgraded Atara Biotherapeutics (NASDAQ:ATRA) from "Sell" to "Hold," reflecting an average "Hold" consensus among analysts with an average price target of $9.50. Despite the upgrade, ATRA shares opened down 4.9% at $8.09, with the company reporting a quarterly loss of …

AdaptHealth (NASDAQ:AHCO) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen has downgraded AdaptHealth (NASDAQ:AHCO) from a "hold" to a "sell" rating, despite the broader consensus of "Moderate Buy" among analysts with an average price target of $10.29. The company's shares opened at $5.81, near their 52-week low, and below their 50-day …

From Apache to Boeing: Israeli AI Company Takes Its AI to the Next Level

Israeli AI company Odysight.ai, whose computer-vision technology is currently used on Israeli Air Force Apache helicopters, has signed an agreement with Boeing. This Memorandum of Agreement allows Odysight.ai to demonstrate its visual sensing and predictive-maintenance platform at two Boeing sites. The collaboration signifies a …

Should I buy Scribe Therapeutics Inc. (SCTX)

Oak Valley Bancorp (OVLY) Stock Hinges On Durable Margin Strength

Coca-Cola (NYSE:KO) steadies as consumer staples payers draw attention

Coca-Cola (NYSE:KO) garnered attention this week after raising its full-year guidance, reinforcing its position as a stable consumer staples payer known for consistent dividend increases over six decades. The company's diversified portfolio, global reach, and disciplined operations contribute to its reliability, especially as market …

Sherwin Williams (SHW) Unveils Water Based Spray Paint For Indoor And Outdoor Use

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Sherwin-Williams (NYSE:SHW) brand Krylon has introduced Krylon Harmony, a new water-based spray paint designed for year-round indoor and outdoor use. The product aims …

Price-Driven Insight from (ZVRA) for Rule-Based Strategy

This article provides a price-driven analysis for Zevra Therapeutics Inc. (NASDAQ: ZVRA), highlighting weak near-term sentiment but strong mid and long-term outlooks. It details institutional trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis, and an exceptional risk-reward short …

Arcutis (ARQT) Q2 2026 Earnings Call Transcript

Patriot National Bancorp (PNBK) Stock Profit Return Still Leaves Doubts

Nektar Therapeutics (NKTR) Stock Slides As Cash Burn Clouds Pipeline Progress

Nektar Therapeutics' stock fell 4% following its Q2 2026 earnings report, despite progress in its autoimmune pipeline, notably rezpegaldesleukin. The market reacted negatively to the company's substantial cash burn, with a quarterly net loss exceeding US$40 million and trailing 12-month losses widening. While the …

TJX Companies (TJX) Nears Earnings, Is The 14% Undervaluation Case Convincing?

Hongkong & Shanghai Hotels Signals Earnings Turnaround

How can Disney get back its narrative momentum?

Investing.com -- Walt Disney (NYSE:DIS) must rebuild its franchise pipeline and become a larger content aggregator if it wants to regain the valuation premium it historically commanded, Barclays analysts said. Disney's valuation has fallen toward multi-decade lows as investors have focused on near-term earnings …

Income Investors Should Know That Jardine Matheson Holdings Limited (SGX:J36) Goes Ex-Dividend Soon

Brian Dyson Obituary (1935 - 2026) - Atlanta, GA - Atlanta Journal-Constitution

Brian Dyson, former Vice Chairman and COO of The Coca-Cola Company, passed away at 90 on August 9, 2026. Born in Argentina, Dyson had a distinguished career with Coca-Cola, led several entrepreneurial ventures, and was known for his athletic pursuits and writing. He is …

How Rapport Therapeutics Inc. (RAPP) Affects Rotational Strategy Timing

This article analyzes Rapport Therapeutics Inc. (RAPP) using AI models to determine its effect on rotational strategy timing. Key findings suggest a strong sentiment supporting an overweight bias, with resistance being tested. The analysis provides specific institutional trading strategies, including position trading, momentum breakout, …

Straits Trading (SGX:S20) Stock Trails Revenue Growth As Losses Persist

Coca-Cola (KO) Lifted Its Guidance, Is The Stock Fully Priced?

What Does Lantheus Holdings (LNTH) FDA Approval Mean For Its Alzheimer’s Push?

Lantheus Holdings received FDA approval for TAUKLARIFY, a tau PET imaging agent for Alzheimer's disease diagnostics, expanding its molecular imaging portfolio beyond prostate cancer. This approval strengthens Lantheus's position in the Alzheimer's imaging market and supports its strategy of diversifying revenue and meeting the …

AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information

Edelson Lechtzin LLP, a national class action law firm, is investigating a data breach at AdaptHealth Corp. that exposed patient data. The breach, disclosed on July 2, 2026, involved a social engineering attack that compromised a third-party contractor's credentials, leading to unauthorized access to …

Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates

Vivos Therapeutics, Inc. (VVOS) reported a Q2 loss of $0.31 per share, which was better than the Zacks Consensus Estimate of a $0.42 loss. However, the company missed revenue estimates, posting $5.15 million against an expected $5.43 million. Despite beating EPS estimates two out …

How TG Therapeutics’ Q2 2026 Revenue Surge And Higher Guidance At TG Therapeutics (TGTX) Has Changed Its Investment Story

US Physical Therapy Appoints New Executive Vice President CFO